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Strategic review of child health
Delivering child health interventions through the 
private sector in low and middle income countries: 
challenges, opportunities, and potential next steps
Universal health coverage requires both the public and private sectors to ensure quality, equity, and 
efficiency in health systems, say Phyllis Awor and colleagues
Key messages
•   Care for most children is sought from 
private health providers  in  the  for-
profit sector in low and middle income 
countries
•   Challenges of private sector engagement 
include its heterogeneous composition, 
poor  quality  of  care,  and  inherent 
market failures
•   Challenges  have  been  overcome 
using existing approaches,  such as 
accreditation,  contracting  out,  use 
of vouchers, social franchising, and 
social marketing as well as innovative 
(although small scale)  introduction 
of  the  Integrated  Community  Case 
Management (iCCM) and Integrated 
Management of Childhood Illnesses 
(IMCI) strategies in the private sector, 
to  improve  quality,  access,  and 
affordability of care
•   Inclusion of private health providers 
in community health systems and an 
implementation research agenda for 
private sector IMCI is recommended
Private health providers are an important source of treatment for common childhood illnesses in low and middle income coun-tries. A recent analysis of 70 
countries showed that the private sector 
provides 63% of treatment for fever or cough 
and 67% of treatment for diarrhoea for sick 
children.1 Care seeking for key maternal 
health services, including institutional deliv-
ery (38%), antenatal care (30%) and mod-
ern contraceptives (39%), is lower1 but still 
significant. In this case the private sector is 
responsible for providing one third or more 
of health services that can affect mother and 
child survival. In addition, most community 
level management of childhood illnesses in 
low income countries is through small (one 
or two rooms) private clinics and the retail 
health sector (drug shops and pharmacies).2 
3 This high use of private health providers 
for management of common childhood ill-
nesses raises questions about the conven-
tional emphasis of critical child healthcare 
in the public sector.
Health  systems  need  to  maximise 
health outcomes and deliver equitable, 
inexpensive, good quality services to entire 
populations.  In  considering  universal 
coverage, the performance of the private 
healthcare sector is often assessed in three 
ways: quality of care, equity, and efficiency. 
This information is used to compare public 
and  private  sector  contributions  and 
progress towards universal health coverage. 
Various systematic reviews highlight poor 
quality of care in both the public and private 
sector in low and middle income countries, 
underlining  the need  for  improvement 
throughout the health system.2 4 Meanwhile, 
fair availability of healthcare may be seen 
as low with private healthcare provision, 
especially given that most private services 
are funded directly by patients themselves, 
favouring  the better off.2 However,  the 
availability of private providers, which 
increases the opportunity for the whole 
population to access care—for example, 
when public provision is weak—can improve 
overall fairness of the health system.5
In view of the low public financing of 
healthcare, high out-of-pocket expenditure 
and the high use of private providers in low 
and middle income countries, we will be 
unable to achieve universal health coverage 
without working with both public and 
private sectors to ensure quality, equity, and 
efficiency.5
We  discuss  the  opportunities  and 
challenges of working with the private sector 
for delivery of child health interventions, 
and propose possible next steps. We draw 
on the findings of the 2016 strategic review 
of Integrated Management of Childhood 
Illnesses (IMCI), coordinated by the World 
Health Organization and Unicef6 and in 
particular, a systematic literature of review 
of evidence on working with the private 
sector, interviews with key informants, and 
country assessments.
Challenges of working with the private sector 
towards public health goals
Working with the private sector for public 
health goals presents challenges owing to 
its heterogeneous, multi-layered, and highly 
segmented structure (table 1). The private 
health sector can be divided into for-profit 
and not-for-profit, and further subdivided 
into formal or informal providers. These 
providers are widely diverse, ranging from 
private doctors and nurses to medical and 
nursing assistants, and even include tradi-
tional healers and drug peddlers (table 1). 
It may be easier to form a partnership with 
large private facilities and hospitals (both 
for-profit and not-for-profit) to improve 
access and quality of care. However, many 
patients in low and middle income countries 
also seek care from the informal and retail 
sector, where regulation is weak.2 Frequent 
recourse to the informal private sector and 
weak regulation make it complicated for 
governments to make firm decisions about 
whether to prohibit, constrain, or encourage 
the sector.7
Furthermore, failures occur in private 
healthcare markets—for  example,  the 
markets may be unable to adequately provide 
public goods, and there may be problems 
with obtaining information from them. The 
market failures in the provision of public 
goods relate to inefficient allocation and 
inadequate supply of goods and services, 
and charging for services that are supposed 
to be free—for example, immunisation. This 
especially affects the poor, who may not 
be able to afford or access private services. 
Imperfect  information and  information 
asymmetry (providers know more than the 
patients) also exist in health markets. This 
can generate adverse selection in insurance 
and provider induced demand for services,8 
which coupled with profit incentives may be 
stronger in the private sector.
Service quality  (which  includes drug 
availability and patient satisfaction) is often 
reported to be better in the private than the 
public sector. Private providers may be more 
responsive as they have greater motivation 
to encourage patients to return and fewer 
financial restrictions than public providers.4 
However,  technical  quality  (including 
provider competence and adherence to 
treatment guidelines) may be lower in the 
private sector.4 5
These characteristics of the private sector 
require  government  to make  a  careful 
analysis of health system bottlenecks and 
a plausible assessment of how a public-
private partnership will improve health 
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outcomes. Governments must ensure equity 
and access to care; affordability; quality of 
care within the diverse private sector; and 
adequate regulation. However, gross public 
sector inadequacies exist in low and middle 
income countries. These include lack of 
medicines, inaccessible health facilities, 
health worker shortages, and high out-of-
pocket expenditure. All these factors justify 
the search  for ways  to  improve service 
delivery  in general,  and also a  careful 
consideration of public-private partnerships. 
These may be more appropriate in some 
settings (eg, informal urban settlements) 
than others, and must be assessed so that 
they do not drain public sector funds and 
clients, where a dominant public sector 
provision is desired.
Opportunities of working with private  
health providers
The important role of the private sector in 
the future of child health delivery was well 
articulated in global key informant inter-
views and country assessments.6 About half 
of the key informants stated that coopera-
tion with the private sector is essential for 
improving child health and cannot be over-
looked because these providers are often 
much closer to the community.6 This was 
particularly emphasised in the assessments 
for Nigeria and India, where the private 
sector is much used. Until now, the private 
sector has been largely neglected owing to 
institutional barriers that have prevented its 
inclusion, the weak ability of the public sec-
tor to perform an effective stewardship role, 
and a general mistrust of the sector.
Over  the  past  10  years,  the  imple-
mentation of programmes which include 
the private sector has steadily increased.9 
Different approaches have been used when 
working with private health providers in 
order to improve quality of care, increase 
availability of goods and services, and to 
ensure affordability, equity and coverage 
of health services. These strategies include 
regulation, accreditation, contracting out, 
social marketing, social franchising, use 
of vouchers, and pre-packaging of drugs.7 
10Box 1 presents existing strategies  for 
working with private health providers 
and summarises  the evidence  for each 
strategy.  For  child health,  contracting 
out (particularly in fragile states), use of 
vouchers, accreditation, social marketing 
and social franchising are the commonly 
used approaches (box 1).
Social  marketing  involves  applying 
principles of commercial marketing to social 
health problems, whereas a social franchise 
is a contractual arrangement between a 
health service provider and a franchise 
organisation, which aims to improve access, 
quality of healthcare, and price regulation11 
(box 1). The intermediary for these strategies 
is often a non-governmental organisation 
with donor funding, raising questions about 
sustainability. Alternatively, management of 
these strategies may be through ministries of 
health and education. The promotional and 
accreditation aspects are worked out, but it 
is generally harder to ensure that the quality 
of care delivered meets required standards.
The employment of social franchising is 
growing. In 2013 alone, Viswanathan et al 
reported the existence of social franchises 
in over 40 countries in Africa, Asia, and 
Latin America, with over 95 000 providers 
operating  as  part  of  social  franchised 
networks.12 These franchises are often led 
by  international organisations such as 
Population Services International, Marie 
Stopes International and FHI 360. They 
take various preventive and  lifesaving 
services related to family planning, maternal 
and child health, tuberculosis, and HIV 
testing to millions of people around the 
world. Additionally, Integrated Community 
Case Management (iCCM) is employed for 
malaria, pneumonia and diarrhoea child 
survival strategy (box 2), through certain 
franchised outlets like those of Population 
Services International.13 The idea is that 
using private sector incentive mechanisms 
and supply chains will enable these services 
to  reach communities more  effectively 
than public  services. However,  formal 
comparative studies of care provided by 
franchised networks versus the public sector 
are generally lacking.
Two other franchised networks, Living 
Goods  (based  in  the  USA)14  and  the 
Bangladesh Rural Advancement Committee 
(BRAC)15 are using the iCCM strategy within 
the private sector in Uganda and Kenya. 
Working  through  a  network  of mainly 
female  community  health  promoters, 
the franchised networks use a non-profit 
entrepreneurial delivery model where the 
community health promoters earn a margin 
on product sales and performance based 
incentives. An evaluation of  the Living 
Goods entrepreneurial model of community 
health delivery in Uganda found that the 
intervention reduced the under-5 mortality 
rate by 25% in comparison with controls.16
These examples highlight the opportunity 
for using existing community based private 
provider networks to  increase access to 
healthcare  and  expand  the  reach  and 
coverage of the IMCI strategy. The quality of 
care for children in the private sector may also 
be improved using IMCI and iCCM strategies.
The evidence for social franchising is 
limited. A 2009 systematic review found 
no studies meeting the rigorous Cochrane 
inclusion  criteria.17  More  research  is 
needed to further evaluate the effect of 
franchising on quality, health,  equity, 
and cost effectiveness and the value of 
franchising in other healthcare sectors.17-19 
In a 2014 systematic review on IMCI in 
Africa, Awor and colleagues found that 
private sector involvement tended to focus 
on single disease interventions (especially 
malaria) rather than integrated management 
of children.20 The review found only one 
study on the IMCI in the private sector,21 
highlighting the need for better evidence 
for the ability of the different private sector 
Table 1 | The heterogeneous and multilayered composition of the private sector
Formal Informal
For profit •  Private hospitals/clinics (outpatient care, inpatient care, multispecialty, 
superspecialty)
•  Private doctors (general physicians)
•  Private registered/licensed pharmacies, drug shops and proprietary patent 
medicine vendors (Nigeria)
•  Private mobile clinics
•  Private nurse/paramedic/other formally trained health worker
•  Public-private mixed—eg, village doctors and village clinics in China, and 
public doctors working privately in India
•  Publicly owned hospitals and public providers with high user fees
•  Private non-biomedical providers and facilities—eg, formally qualified 
AYUSH practitioners in India and practitioners of Chinese medicine/ 
integrated medicine in China
•  Unregistered pharmacies and drug shops
•  Public sector frontline health workers providing private healthcare beyond 
their scope of work, for a fee
•  Private practitioners of allopathic medicine; may be commonly referred 
to as small doctors or private doctors in India and village doctors in 
Bangladesh.
•  Traditional healers
•  Friends and relatives
•  Drug peddlers and vendors
Not for profit •  Non-governmental hospitals/clinics—eg, LV Prasad Eye Hospital, India
•  Faith based hospitals such as mission hospitals
•  Community based depot holders and other fieldworkers
•  Public-private partnerships between governments and NGOs to deliver health 
services such as mobile clinics or delivery centres in hard to reach areas
•  It is possible for not-for-profit entities to function informally—eg, small 
charities and unrecognised spiritual healers
AYUSH=Ayurveda, yoga and naturopathy, Unani, Siddha, and homeopathy; NGOs=non-governmental organisations.
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segments to provide integrated care for 
children (box 2). To support a programme of 
child health interventions, evidence needs 
to be collected through operational research 
in conjunction with the existing wide scale 
private provider networks. Donors who 
support private sector initiatives should 
also see investment in rigorous research 
as a priority for gradually increasing the 
evidence to scale up successful models.
Figure 1 provides an overview of  the 
challenges, opportunities, and possible 
next steps for working with private health 
providers to improve child health outcomes 
in low and middle income countries.
Box 1: Approaches for working with private health providers for the delivery of child health interventions
Social marketing
Social marketing is the application of commercial marketing to social and health problems, in order to increase population coverage of effective 
and affordable interventions.11 It may include mass promotional activities, branding, labelling, pre-packaging and subsidy of public health 
products. It has been used to create demand for health products, including contraceptives, mosquito nets10 and malaria medicines, even through 
for-profit channels, where these commodities are often subsidised. It has also been used to positively influence health related behaviour, 
including immunisation, use of oral rehydration therapy and HIV prevention.
Reviews on commodity social marketing highlight the importance of an integrated package, including mass media, training of healthcare 
providers, patient outreach and the concurrent supply of the commodities and services being promoted, for the strategy to be effective.28
Social franchising
A franchise is a contractual arrangement between a health service provider and a franchise organisation, which aims to improve access to 
quality and price controlled services. Franchisees are trained in standardised practices for which prices are predefined, and they benefit from 
advertising the logo or franchise name. In return, franchisees may be required to comply with a minimum sales volume, quality standards, and 
pay a membership fee to the franchiser. The franchise organisation (a government or donor-sponsored non-governmental organisation) monitors 
providers and subsidises the network.
Franchising is associated with increased numbers of clients, patient satisfaction, physical accessibility, and improved quality. Findings related 
to healthcare use—namely, the effect on health, efficiency, and provider outcomes—are mixed. Further research is needed to elucidate the effect 
of franchising for quality, health impact, equity, cost effectiveness, and the value of franchising in other healthcare sectors like child health.17 18 19
Numerous social franchising programmes already exist around the world, providing an opportunity to expand access to care rapidly and 
standardise and improve the quality of care. This could form the basis for evaluation of private sector initiatives, provided that evaluation is built 
into further expansion of the social franchises.
Vouchers
Vouchers are a form of demand-side subsidy that recipients use as part or full payment for a product or service from identified providers. 
Distribution of vouchers can be targeted—for example, to the poorest households or pregnant women. Vouchers could be competitively redeemed 
through use of different providers, or non-competitively assigned to a particular provider.11 The use of vouchers has been shown to improve 
access to maternal healthcare, although the problem of misuse of the subsidy has also been identified.23
Accreditation
Accreditation is a strategy to improve and control quality of services provided at facility level through oversight by an independent quality control 
evaluation body (government or a non-governmental organisation). It may include training providers in standardised practices.10 Accreditation is 
similar to franchising, although it is often voluntary, unlike the contractual relationship between franchisee/franchiser. Accreditation has been 
successfully used for WHO laboratory quality control, and within the pharmaceutical sector, to improve the quality of drug dispensing.
Contracting out
Contracting out is a purchasing mechanism used to acquire specified services, of defined quality, at an agreed price, from a specific private provider 
and for a specific period of time. Governments may purchase clinical or non-clinical services from private providers to complement public provision. 
Contracting out has been shown to be effective at increasing access and use of health services, particularly in conflict or fragile states.22 29
Pre-packaging
Drugs may be packaged in predefined doses adequate for the targeted population group and length of treatment regimen.10 This is particularly 
useful for paediatric medicines and is used to improve provider and patient adherence to treatment regimens. Pre-packaging is sometimes used 
with commodity social marketing.
Training
Training activities are often integrated into other strategies, including franchising, accreditation, and social marketing interventions. They can 
take various forms, including formal training sessions, vendor-to-vendor education, distribution of guidelines and job aids.
Literature reviews consistently show that provider training is insufficient to change practice or improve quality of care in the private sector.24 30 
This is because various other factors, including supply chain management, patient expectation, profit motivation, etc, affect provider practice 
more strongly. Hence approaches that combine provider training with consumer education yield better results.
Regulation
Regulatory interventions are used to set up and ensure adequate technical quality of service providers. Regulation involves setting rules, 
sanctions, and ensuring adequate enforcement. Basic regulatory frameworks exist in most countries, particularly for pre-service training, 
registration and licensing requirements for health workers and premises. Pharmaceutical market regulation aims to limit the availability of 
harmful drugs and unregistered products, minimise drug misuse, control the sale of specific drugs through prescriptions and regulate drug 
manufacture and importation. Regulation has a crucial balancing role within the private sector, although, inadequate resources are typically 
allocated for monitoring and enforcing regulations. Co-regulation with professional associations, civil society, and communities can provide 
additional benefit.
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Next steps
Evidence is growing in favour of private sec-
tor approaches that are relevant for improv-
ing child health outcomes. These include 
contracting out (for example, of primary 
healthcare in the post-conflict states of 
Cambodia and Rwanda),22 use of vouchers 
to increase access to delivery services for 
poor populations,23 accreditation of health 
facilities and laboratories, social marketing 
and social franchising. However, for maxi-
mum benefit, these strategies must be used 
in various combinations, as single interven-
tions are generally less effective24 in both 
public and private health sectors. In addi-
tion, it is important to support wide scale 
use of social health insurance to reduce 
out-of-pocket health expenditure, through 
pooling contributions from individual com-
munity members, governments, and exter-
nal funding that is available for health in low 
and middle income countries.
Given the high healthcare seeking  in 
the private sector, governments (which are 
responsible for the health of their citizens) 
cannot afford to leave the sector unregulated. 
The market influences on the private sector 
should guide the conceptualisation, design 
and implementation of interventions. There 
are multiple  institutions that  influence 
health markets, many people  involved, 
and an interplay of formal and informal 
rules within  these market systems. For 
this reason, interventions that focus too 
narrowly on specific aspects—for example, 
training—are  likely  to  fail  24  because 
they do not adequately anticipate and 
account for complex interactions among 
the existing stakeholders.25 Additionally, 
health markets exist within the broader 
health system, which require a “systems 
thinking” approach to working with private 
providers.26 Systems thinking considers the 
effects of a particular intervention on other 
health system building blocks and enables 
holistic understanding of interactions with 
the rest of the health system. This increases 
understanding of both the intended and 
unintended consequences of private sector 
interventions.25 27
To improve access to healthcare, the next 
logical step is to include private health 
providers in community health systems. 
Private health providers at community level 
could be used to expand access to integrated 
care for children with common illnesses, 
such as malaria, pneumonia, and diarrhoea. 
The  private  sector  supply  chain  and 
incentive mechanisms can be used to ensure 
availability of drugs and commodities in the 
community, probably more effectively than 
through public channels. This is dependent 
on the type of private sector that exists in a 
specific setting.
Strong regulation required
The opportunity Challenges Next steps for engagement
Large scale social franchise
networks – over 95 000
private health providers;
over 40 countries
Influences on private sector
should guide interventions –
balance of incentives
and regulation
Private sector engagement for
integrated management
of childhood illnesses
iCCM and IMCI strategies
to improve quality and
access in private sector
An implementation research
agenda for private sector
integrated care for children
Evidence of improved access,
quality, and child survival
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iCCM in private sector
High care seeking for childhood
illnesses in private sector
Inequitable distribution
and supply of services
Heterogeneous private providers
Unaordable services
Poor quality care
Ineciency
Poor regulation
A systems thinking approach
Fig 1 | Challenges, opportunities, and next steps for working with the private sector to improve child 
health outcomes in low and middle income settings. iCCM=Integrated Community Case Management; 
IMCI=Integrated Management of Childhood Illnesses
Box 2: The need for Integrated Management of Childhood Illnesses (IMCI) within the private sector
IMCI
Since 1995, IMCI has been the key strategy for treating sick children and improving child survival in countries with high child mortality. IMCI 
provides guidance on treatment and care for the major childhood illness, including malaria, pneumonia and diarrhoea, and malnutrition. It has 
three components: improving health worker skills, strengthening health systems, and family and community practices. IMCI has been shown 
to improve health worker performance and quality of care, but it did not achieve the expected effect on mortality mainly owing to delayed care 
seeking.31
Integrated Community Case Management (iCCM)
To improve the treatment seeking practices for sick children under IMCI, community case management was recommended, to complement the 
health facility based services. Community case management includes treatment of sick children at the community level and promotes timely care 
seeking and referral to health facilities. iCCM is supported by WHO and Unicef to increase access to care for malaria, pneumonia, and diarrhoea in 
children aged <5 years.
Low use of the private sector for integrated management of malaria, pneumonia, and diarrhoea
In 2014, Awor et al reviewed the literature on experience with iCCM within both the public and private sectors.20 They aimed at understanding 
the degree to which the private sector was used for IMCI. Evaluation studies investigating the effect of introducing an intervention with drugs or 
diagnostics, for malaria, pneumonia, or diarrhoea, within both the public and the private sector were included. This review found four times as 
many evaluation studies referring to malaria, pneumonia, or diarrhoea in the public sector (49 studies) as in similar studies within the private 
sector (13 studies). Most public sector iCCM studies evaluated the introduction of drugs and/or diagnostics for two or more illnesses (malaria, 
pneumonia, and diarrhoea), while almost all studies in the private sector examined interventions for one disease only, malaria.20 The studies 
were all made within retail drug shops.
These results indicate that the private sector has focused more on interventions for a single disease (especially malaria) and not integrated care. 
Clearly, the private sector has not been effectively used for integrated child care. This follows the historical pattern of single disease focus in the 
public sector (starting with home management of malaria), which has now evolved into the iCCM strategy.
To improve rational drug use and quality of care for sick children, the logical next step should be private sector engagement at community 
level, for integrated service delivery for acute febrile illness in children. This might include provision of alternative appropriate care if the malaria 
diagnostic test is negative. In this regard, iCCM is an appropriate strategy, which should be further explored.
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It is possible for IMCI and iCCM strategies 
to improve quality of care in the private 
sector,  provided  that  they  are  adapted 
for use in the sector. Adaptation should 
include recommendations for the price of 
drugs, diagnostics, and any price subsidies; 
determining who will supervise the private 
providers in the community; and education of 
communities about management of childhood 
illnesses and what to expect in both the public 
and private sectors. At the same time routine 
IMCI/iCCM activities and interventions should 
continue. Conversely, the private sector can 
improve the reach and coverage of IMCI, 
given the wide scale of healthcare seeking in 
the sector. However, there is need for more 
evidence on the effect of using the iCCM 
strategy within the private sector on child 
health outcomes; and how it can be used 
within existing private sector approaches 
like social franchising, in conjunction with 
programmes  in different settings. Thus, 
research into private sector integrated care 
of febrile illness in children needs to be 
carried out, in conjunction with private sector 
programmes, in multiple settings.
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